192 related articles for article (PubMed ID: 28390392)
1. Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
Li X
BMC Cancer; 2017 Apr; 17(1):252. PubMed ID: 28390392
[TBL] [Abstract][Full Text] [Related]
2. GRWD1-WDR5-MLL2 Epigenetic Complex Mediates H3K4me3 Mark and Is Essential for Kaposi's Sarcoma-Associated Herpesvirus-Induced Cellular Transformation.
Wei S; Lu S; Liang L; Wang X; Li W; Li T; Chen L; Ju E; Zhang X; Lai Z; Huang Y; Lu X; Gao SJ
mBio; 2021 Dec; 12(6):e0343121. PubMed ID: 34933446
[TBL] [Abstract][Full Text] [Related]
3. Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.
Lee JJ; Sholl LM; Lindeman NI; Granter SR; Laga AC; Shivdasani P; Chin G; Luke JJ; Ott PA; Hodi FS; Mihm MC; Lin JY; Werchniak AE; Haynes HA; Bailey N; Liu R; Murphy GF; Lian CG
Clin Epigenetics; 2015; 7(1):59. PubMed ID: 26221190
[TBL] [Abstract][Full Text] [Related]
4. Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients.
Yin S; Yang J; Lin B; Deng W; Zhang Y; Yi X; Shi Y; Tao Y; Cai J; Wu CI; Zhao G; Hurst LD; Zhang J; Hu L; Kong X
Sci Rep; 2014 Aug; 4():6036. PubMed ID: 25112956
[TBL] [Abstract][Full Text] [Related]
5. Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB 151111 (Alliance).
Augert A; Zhang Q; Bates B; Cui M; Wang X; Wildey G; Dowlati A; MacPherson D
J Thorac Oncol; 2017 Apr; 12(4):704-713. PubMed ID: 28007623
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome.
Hannibal MC; Buckingham KJ; Ng SB; Ming JE; Beck AE; McMillin MJ; Gildersleeve HI; Bigham AW; Tabor HK; Mefford HC; Cook J; Yoshiura K; Matsumoto T; Matsumoto N; Miyake N; Tonoki H; Naritomi K; Kaname T; Nagai T; Ohashi H; Kurosawa K; Hou JW; Ohta T; Liang D; Sudo A; Morris CA; Banka S; Black GC; Clayton-Smith J; Nickerson DA; Zackai EH; Shaikh TH; Donnai D; Niikawa N; Shendure J; Bamshad MJ
Am J Med Genet A; 2011 Jul; 155A(7):1511-6. PubMed ID: 21671394
[TBL] [Abstract][Full Text] [Related]
7. Somatic Variations in Cervical Cancers in Indian Patients.
Das P; Bansal A; Rao SN; Deodhar K; Mahantshetty U; Shrivastava SK; Sivaraman K; Mulherkar R
PLoS One; 2016; 11(11):e0165878. PubMed ID: 27829003
[TBL] [Abstract][Full Text] [Related]
8. MLL2 and KDM6A mutations in patients with Kabuki syndrome.
Miyake N; Koshimizu E; Okamoto N; Mizuno S; Ogata T; Nagai T; Kosho T; Ohashi H; Kato M; Sasaki G; Mabe H; Watanabe Y; Yoshino M; Matsuishi T; Takanashi J; Shotelersuk V; Tekin M; Ochi N; Kubota M; Ito N; Ihara K; Hara T; Tonoki H; Ohta T; Saito K; Matsuo M; Urano M; Enokizono T; Sato A; Tanaka H; Ogawa A; Fujita T; Hiraki Y; Kitanaka S; Matsubara Y; Makita T; Taguri M; Nakashima M; Tsurusaki Y; Saitsu H; Yoshiura K; Matsumoto N; Niikawa N
Am J Med Genet A; 2013 Sep; 161A(9):2234-43. PubMed ID: 23913813
[TBL] [Abstract][Full Text] [Related]
9. How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum.
Banka S; Veeramachaneni R; Reardon W; Howard E; Bunstone S; Ragge N; Parker MJ; Crow YJ; Kerr B; Kingston H; Metcalfe K; Chandler K; Magee A; Stewart F; McConnell VP; Donnelly DE; Berland S; Houge G; Morton JE; Oley C; Revencu N; Park SM; Davies SJ; Fry AE; Lynch SA; Gill H; Schweiger S; Lam WW; Tolmie J; Mohammed SN; Hobson E; Smith A; Blyth M; Bennett C; Vasudevan PC; García-Miñaúr S; Henderson A; Goodship J; Wright MJ; Fisher R; Gibbons R; Price SM; C de Silva D; Temple IK; Collins AL; Lachlan K; Elmslie F; McEntagart M; Castle B; Clayton-Smith J; Black GC; Donnai D
Eur J Hum Genet; 2012 Apr; 20(4):381-8. PubMed ID: 22126750
[TBL] [Abstract][Full Text] [Related]
10. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.
Dubuc AM; Remke M; Korshunov A; Northcott PA; Zhan SH; Mendez-Lago M; Kool M; Jones DT; Unterberger A; Morrissy AS; Shih D; Peacock J; Ramaswamy V; Rolider A; Wang X; Witt H; Hielscher T; Hawkins C; Vibhakar R; Croul S; Rutka JT; Weiss WA; Jones SJ; Eberhart CG; Marra MA; Pfister SM; Taylor MD
Acta Neuropathol; 2013 Mar; 125(3):373-84. PubMed ID: 23184418
[TBL] [Abstract][Full Text] [Related]
11. MLL2 mutation spectrum in 45 patients with Kabuki syndrome.
Paulussen AD; Stegmann AP; Blok MJ; Tserpelis D; Posma-Velter C; Detisch Y; Smeets EE; Wagemans A; Schrander JJ; van den Boogaard MJ; van der Smagt J; van Haeringen A; Stolte-Dijkstra I; Kerstjens-Frederikse WS; Mancini GM; Wessels MW; Hennekam RC; Vreeburg M; Geraedts J; de Ravel T; Fryns JP; Smeets HJ; Devriendt K; Schrander-Stumpel CT
Hum Mutat; 2011 Feb; 32(2):E2018-25. PubMed ID: 21280141
[TBL] [Abstract][Full Text] [Related]
12. COMPASS Ascending: Emerging clues regarding the roles of MLL3/KMT2C and MLL2/KMT2D proteins in cancer.
Fagan RJ; Dingwall AK
Cancer Lett; 2019 Aug; 458():56-65. PubMed ID: 31128216
[TBL] [Abstract][Full Text] [Related]
13. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
14. Predictive Role of TP53, PIK3CA and MLL2 in ER+ HER2+ Breast Bancer: Biomarker Analysis of Neo-ALL-IN [NCT 01275859].
Park JH; Ahn JH; Kim JE; Jung KH; Gong G; Lee HJ; Son BH; Ahn SH; Kim HH; Shin HJ; Moon DH; Kim D; Kim SB
Anticancer Res; 2020 Oct; 40(10):5883-5893. PubMed ID: 32988919
[TBL] [Abstract][Full Text] [Related]
15. Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors.
Morcillo-Garcia S; Noblejas-Lopez MDM; Nieto-Jimenez C; Perez-Peña J; Nuncia-Cantarero M; Győrffy B; Amir E; Pandiella A; Galan-Moya EM; Ocana A
PLoS One; 2019; 14(4):e0209134. PubMed ID: 30990809
[TBL] [Abstract][Full Text] [Related]
16. Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
Lee SY; Chae DK; Lee SH; Lim Y; An J; Chae CH; Kim BC; Bhak J; Bolser D; Cho DH
BMC Cancer; 2020 Jul; 20(1):694. PubMed ID: 32718341
[TBL] [Abstract][Full Text] [Related]
17. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
[TBL] [Abstract][Full Text] [Related]
18. N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer.
Zhang H; Kong W; Zhao X; Han C; Liu T; Li J; Song D
BMC Genom Data; 2022 Jan; 23(1):8. PubMed ID: 35042477
[TBL] [Abstract][Full Text] [Related]
19. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
20. MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study.
Makrythanasis P; van Bon BW; Steehouwer M; Rodríguez-Santiago B; Simpson M; Dias P; Anderlid BM; Arts P; Bhat M; Augello B; Biamino E; Bongers EM; Del Campo M; Cordeiro I; Cueto-González AM; Cuscó I; Deshpande C; Frysira E; Izatt L; Flores R; Galán E; Gener B; Gilissen C; Granneman SM; Hoyer J; Yntema HG; Kets CM; Koolen DA; Marcelis Cl; Medeira A; Micale L; Mohammed S; de Munnik SA; Nordgren A; Psoni S; Reardon W; Revencu N; Roscioli T; Ruiterkamp-Versteeg M; Santos HG; Schoumans J; Schuurs-Hoeijmakers JH; Silengo MC; Toledo L; Vendrell T; van der Burgt I; van Lier B; Zweier C; Reymond A; Trembath RC; Perez-Jurado L; Dupont J; de Vries BB; Brunner HG; Veltman JA; Merla G; Antonarakis SE; Hoischen A
Clin Genet; 2013 Dec; 84(6):539-45. PubMed ID: 23320472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
